Description
The first International congress “Genetics and the heart” took place in Moscow on 24-25 January 2020. The leading specialists in cardiology and molecular genetics from Russia and foreign countries (Israel, USA, Italy, Great Britain, Germany, Spain) participated in the event. Experts from Tyumen Cardiology Research Center were also among the listeners.
The first International congress “Genetics and the heart” took place in Moscow on 24-25 January 2020. The leading specialists in cardiology and molecular genetics from Russia and foreign countries (Israel, USA, Italy, Great Britain, Germany, Spain) participated in the event. Experts from Tyumen Cardiology Research Center were also among the listeners.
Tatiana Petelina, MD, PhD, Deputy Director for Research, Head of the Laboratory of Clinical & Diagnostic and Molecular & Genetic Studies, and Anna Zabytova, MD, Clinical laboratory diagnostics specialist, have listened to the recent reports on the hereditary disorders of lipid metabolism, problems of hereditary cardiovascular diseases in children, genetics of arterial hypertension and thrombophilia, hereditary arrhythmias, cardiooncology and much more.
Dr. Petelina told that at the plenary sessions populational researches results of which can potentially lead to reveal of new medications targets in case of cardiovascular diseases were presented. Professor Antonis Pantazis from Great Britain presented a report on hereditary cardiovascular diseases in sports. He defined limitations of doing professional and amateur sports. Professor Igor Efimov, MD, PhD, Head of the biochemical technologies department of George Washington University, delivered a report on transcriptomics of a man’s heart. The study of this topic provides an opportunity to better understand complex biological systems, as well as the existing potential for the identification and development of new biomarkers. Professor Repin A.N., MD, PhD, Head of the Department of General Clinical Cardiology and Epidemiology of Cardiovascular Diseases of the Research Institute of Cardiology (Tomsk) published a study on the contribution of genetic factors to the development of depression and coronary heart disease.
The congress was supported by the National Research League of Cardiology Genetics. For two days, interactive discussions were held, the place of modern genetic methods and the possibilities of imaging techniques in the management of patients with hereditary myocardial diseases, canalopathy, aortic diseases, dyslipidemia, and early forms of atherosclerosis was discussed.
Dr. Zabytova shared that this congress has become the most important international event for the professional community of medical geneticists and cardiologists. The program covered the widest range of the most relevant scientific and practical developments in medical genetics, such as mass parallel sequencing in the clinical practice of cardiovascular diseases (a method for determining the nucleotide sequence of DNA and RNA by simultaneously analyzing billions of individual molecules). The congress highlighted current trends in the use of bioinformatics in various aspects of the analysis of genetic data of cardiovascular pathology and demonstrated the creation of a bioinformatics protocol that determines changes in a gene, confirms a clinical diagnosis, and identifies carriers and the risk of developing a disease. The reports of many Russian experts confirmed that domestic medical genetics is not inferior in terms of its level to world leaders.
